| Zacks Company Profile for Codexis, Inc. (CDXS : NSDQ) |
|
|
| |
| • Company Description |
| Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis? proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes.
Number of Employees: 188 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $3.11 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 878,040 shares |
| Shares Outstanding: 82.85 (millions) |
| Market Capitalization: $257.65 (millions) |
| Beta: 2.52 |
| 52 Week High: $6.08 |
| 52 Week Low: $1.90 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
38.22% |
33.05% |
| 12 Week |
47.39% |
23.98% |
| Year To Date |
-34.80% |
-38.94% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
200 PENOBSCOT DRIVE
-
REDWOOD CITY,CA 94063
USA |
ph: 650-421-8100
fax: 650-421-8102 |
ir@codexis.com |
http://www.codexis.com |
|
|
| |
| • General Corporate Information |
Officers
Stephen Dilly - President; and Chief Executive Officer;Chairman of
Georgia Erbez - Chief Financial Officer
Raymond De Vre - Director
Byron L. Dorgan - Director
Esther Martinborough - Director
|
|
Peer Information
Codexis, Inc. (CORR.)
Codexis, Inc. (RSPI)
Codexis, Inc. (CGXP)
Codexis, Inc. (BGEN)
Codexis, Inc. (GTBP)
Codexis, Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 192005106
SIC: 2860
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
|
|
Share - Related Items
Shares Outstanding: 82.85
Most Recent Split Date: (:1)
Beta: 2.52
Market Capitalization: $257.65 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-0.15 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-0.67 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 4.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/14/25 |
|
|
|
| |
